ONCOLOGY Nurse Edition April 2008, Vol 22 No 4

Publication
Article
Oncology Nurse EditionONCOLOGY Nurse Edition Vol 22 No 4
Volume 22
Issue 4


Main Articles

 


 

  • PATIENT INFORMATION: Peripheral Neuropathy

Articles in this issue
The Grant et al Article Reviewed
Peripheral Neuropathy and Cancer
mTOR* Inhibitors *mammalian target of rapamycin
Cancer: Thinking Beyond the Disease
ONCOLOGY Nurse Edition April 2008, Vol 22 No 4
Hearing Loss in Pediatric Cancer Survivors Treated With Cisplatin
The Gabriel Article Reviewed
Providing Palliative Care for the Newly Diagnosed Cancer Patient: Concepts and Resources
Menopausal Symptoms Following Tamoxifen Treatment for Breast Cancer
The Evolving Paradigm of Adult Cancer Survivor Care
Sexuality and Body Image Concerns After Treatment for Breast Cancer
Recent Videos
2 experts in this video
2 experts in this video
Beta emitters like 177Lu-rosopatamab may offer built-in PSMA imaging during the treatment of patients with metastatic castration-resistant prostate cancer.
Ongoing ctDNA analysis may elucidate outcomes associated with divarasib plus migoprotafib for those with KRAS G12C–positive NSCLC.
2 experts are featured in this series.
2 experts are featured in this series.
Related Content
Pathological complete response was higher among patients with ERBB2–positive gastric cancer or GEJ adenocarcinoma treated with atezolizumab vs without.

Atezolizumab/Trastuzumab Plus Chemotherapy Shows Efficacy in Gastric Cancer

Roman Fabbricatore
May 7th 2025
Article

Pathological complete response was higher among patients with ERBB2–positive gastric cancer or GEJ adenocarcinoma treated with atezolizumab vs without.

Therapies like betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.

Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia

Nora M. Gibson, MD, MSCE;Taha Al-Juhaishi, MD
May 5th 2025
Podcast

Therapies like betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.

73 Short- and Long-Term Outcomes in Use of Titanium-Coated Polypropylene Meshes in Immediate Breast Reconstruction: A Cost-Effective and Safe Option?

73 Short- and Long-Term Outcomes in Use of Titanium-Coated Polypropylene Meshes in Immediate Breast Reconstruction: A Cost-Effective and Safe Option?

Hudhaifah Shaker;Eleanor Rees;Ian J Whitehead;Ansar Farooq;Noaman Sarfraz
May 6th 2025
Article
Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer

Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer

Manojkumar Bupathi, MD, MS;Manojkumar Bupathi, MD, MS
May 1st 2025
Podcast

Oncology Decoded hosts discuss adjuvant therapy in kidney cancer, including research, treatment strategies, and management of recurrence.

FDA Gives Fast Track Designation to Givinostat for Polycythemia Vera

FDA Gives Fast Track Designation to Givinostat for Polycythemia Vera

Tim Cortese
May 6th 2025
Article

The phase 3 GIV-IN PV trial is evaluating the efficacy and safety of givinostat vs hydroxyurea in patients with polycythemia vera.

HITOCH After Surgery Appears Safe, May Improve Survival in Mesothelioma

HITOCH After Surgery Appears Safe, May Improve Survival in Mesothelioma

Tim Cortese
May 6th 2025
Article

A systematic review shows that patients with mesothelioma who received HITOCH experienced between 13 to 35 months of survival.